Search

127 Result(s)
Sort by

Lothar Halmer

Lothar Halmer

Dr. Lothar Halmer is our Chief Quality Officer, and proud to have built a 25-year career with us.
FDA approval NexGard PLUS for dogs

FDA approval NexGard PLUS for dogs

Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS - A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites
Anna Race

Anna Race

Human Pharma's Sales Director for UK & Ireland, Anna Race discusses how she enjoys making a difference within the company.
Phase II trials for patients with bronchiectasis

Phase II trials for patients with bronchiectasis

Bronchiectasis is a chronically progressive pulmonary disease. Boehringer Ingelheim investigates a potential new treatment option in two Phase II trials.
Have you heard about monkeypox

Have you heard about monkeypox

Monkeypox: What exactly is it, how is the virus transmitted, what are the most noticeable symptoms?
Connect the Docs

Connect the Docs

Experts discuss interconnectivitiy of heart failure, diabetes, and kidney disease and the importance of early diagnosis.
Scam alert

Scam alert

A recruitment scam involving Boehringer Ingelheim is circulating.
Questions and Answers

Questions and Answers

Answers to common questions from both patients and health care professionals regarding Compassionate Use of experimental medications.
Fredrik Gruenenfelder

Fredrik Gruenenfelder

, Lead Risk Management Physician, talks about his career journey, from veterinarian to playing a key role in keeping patients safe.
Edda Dankmeyer

Edda Dankmeyer

Edda Dankmeyer leads Sustainable Development Communications and explains how sustainable development can bea key differentiator for the company.
EHS management approach

EHS management approach

We protect our employees, facilities and the environment from harmful influences, conserve natural resources and promote environmental awareness
The big, the bold, and the few

The big, the bold, and the few

In the animal health industry, fewer players are vying for bigger market shares. What does that mean for companies, veterinarians, and consumers?